200 related articles for article (PubMed ID: 30483773)
1. Functional role of RBM10 in lung adenocarcinoma proliferation.
Sun X; Jia M; Sun W; Feng L; Gu C; Wu T
Int J Oncol; 2019 Feb; 54(2):467-478. PubMed ID: 30483773
[TBL] [Abstract][Full Text] [Related]
2. RBM10 inhibits cell proliferation of lung adenocarcinoma via RAP1/AKT/CREB signalling pathway.
Jin X; Di X; Wang R; Ma H; Tian C; Zhao M; Cong S; Liu J; Li R; Wang K
J Cell Mol Med; 2019 Jun; 23(6):3897-3904. PubMed ID: 30955253
[TBL] [Abstract][Full Text] [Related]
3. Synaptotagmin 12 (SYT12) Gene Expression Promotes Cell Proliferation and Progression of Lung Adenocarcinoma and Involves the Phosphoinositide 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway.
Liu K; Luo J; Shao C; Ren Z; Sun S; Zhu Y; Zhou H; Jiang Z; Li X; Gu W; Xu Y; Qiang Y; Ren B; Xu L; Wu H; Shen Y
Med Sci Monit; 2020 Feb; 26():e920351. PubMed ID: 32108133
[TBL] [Abstract][Full Text] [Related]
4. LncRNA TP73-AS1 promoted the progression of lung adenocarcinoma via PI3K/AKT pathway.
Liu C; Ren L; Deng J; Wang S
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30541897
[TBL] [Abstract][Full Text] [Related]
5. Exosomal lncRNA FOXD3-AS1 upregulates ELAVL1 expression and activates PI3K/Akt pathway to enhance lung cancer cell proliferation, invasion, and 5-fluorouracil resistance.
Mao G; Mu Z; Wu DA
Acta Biochim Biophys Sin (Shanghai); 2021 Nov; 53(11):1484-1494. PubMed ID: 34605863
[TBL] [Abstract][Full Text] [Related]
6. LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway.
Wei C; Dong X; Lu H; Tong F; Chen L; Zhang R; Dong J; Hu Y; Wu G; Dong X
J Exp Clin Cancer Res; 2019 Feb; 38(1):95. PubMed ID: 30791942
[TBL] [Abstract][Full Text] [Related]
7. miRNA-125b regulates apoptosis of human non-small cell lung cancer via the PI3K/Akt/GSK3β signaling pathway.
Wang Y; Zhao M; Liu J; Sun Z; Ni J; Liu H
Oncol Rep; 2017 Sep; 38(3):1715-1723. PubMed ID: 28713974
[TBL] [Abstract][Full Text] [Related]
8. TRB3 interacts with ERK and JNK and contributes to the proliferation, apoptosis, and migration of lung adenocarcinoma cells.
Cao X; Fang X; Malik WS; He Y; Li X; Xie M; Sun W; Xu Y; Liu X
J Cell Physiol; 2020 Jan; 235(1):538-547. PubMed ID: 31256425
[TBL] [Abstract][Full Text] [Related]
9. APE1 stimulates EGFR-TKI resistance by activating Akt signaling through a redox-dependent mechanism in lung adenocarcinoma.
Lu GS; Li M; Xu CX; Wang D
Cell Death Dis; 2018 Oct; 9(11):1111. PubMed ID: 30382076
[TBL] [Abstract][Full Text] [Related]
10. The role of RBM10 mutations in the development, treatment, and prognosis of lung adenocarcinoma.
Li Z; Xue Q; Xu J; Zhang P; Ding B
Cell Cycle; 2020 Nov; 19(21):2918-2926. PubMed ID: 33064970
[TBL] [Abstract][Full Text] [Related]
11. RBM10, a New Regulator of p53.
Jung JH; Lee H; Zeng SX; Lu H
Cells; 2020 Sep; 9(9):. PubMed ID: 32947864
[TBL] [Abstract][Full Text] [Related]
12. RFC3 induces epithelial‑mesenchymal transition in lung adenocarcinoma cells through the Wnt/β‑catenin pathway and possesses prognostic value in lung adenocarcinoma.
Gong S; Qu X; Yang S; Zhou S; Li P; Zhang Q
Int J Mol Med; 2019 Dec; 44(6):2276-2288. PubMed ID: 31661124
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA‑21 increases cell viability and suppresses cellular apoptosis in non‑small cell lung cancer by regulating the PI3K/Akt signaling pathway.
Wang T; Cai Z; Hong G; Zheng G; Huang Y; Zhang S; Dai J
Mol Med Rep; 2017 Nov; 16(5):6506-6511. PubMed ID: 28901419
[TBL] [Abstract][Full Text] [Related]
14. CD73 (NT5E) Promotes the Proliferation and Metastasis of Lung Adenocarcinoma through the EGFR/AKT/mTOR Pathway.
Zhang H; Cao Y; Tang J; Wang R
Biomed Res Int; 2022; 2022():9944847. PubMed ID: 35813221
[TBL] [Abstract][Full Text] [Related]
15. SLC39A5 promotes lung adenocarcinoma cell proliferation by activating PI3K/AKT signaling.
Liu Z; Hu Z; Cai X; Liu S
Pathol Res Pract; 2021 Aug; 224():153541. PubMed ID: 34252710
[TBL] [Abstract][Full Text] [Related]
16. DEK promotes the proliferation and invasion of lung cancers and indicates poor prognosis in lung adenocarcinomas.
Yang MQ; Bai LL; Lei L; Zheng YW; Wang Z; Li ZH; Liu CC; Huang WJ; Xu HT
Oncol Rep; 2020 Apr; 43(4):1338-1348. PubMed ID: 32020224
[TBL] [Abstract][Full Text] [Related]
17. miRNA-223 is an anticancer gene in human non-small cell lung cancer through the PI3K/AKT pathway by targeting EGFR.
Ma HP; Kong WX; Li XY; Li W; Zhang Y; Wu Y
Oncol Rep; 2019 Mar; 41(3):1549-1559. PubMed ID: 30747217
[TBL] [Abstract][Full Text] [Related]
18. XPC inhibition rescues cisplatin resistance via the Akt/mTOR signaling pathway in A549/DDP lung adenocarcinoma cells.
Teng X; Fan XF; Li Q; Liu S; Wu DY; Wang SY; Shi Y; Dong M
Oncol Rep; 2019 Mar; 41(3):1875-1882. PubMed ID: 30628719
[TBL] [Abstract][Full Text] [Related]
19. Silencing of Receptor Tyrosine Kinase ROR1 Inhibits Tumor-Cell Proliferation via PI3K/AKT/mTOR Signaling Pathway in Lung Adenocarcinoma.
Liu Y; Yang H; Chen T; Luo Y; Xu Z; Li Y; Yang J
PLoS One; 2015; 10(5):e0127092. PubMed ID: 25978653
[TBL] [Abstract][Full Text] [Related]
20. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
Zhou Y; Li S; Li J; Wang D; Li Q
Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]